Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07033195 · ClinicalTrials.gov registry record · NA
Virtual Reality Treatment for Adults With Chronic Back Pain (VRNT)
A NA study of Chronic Pain and Chronic Back Pain, sponsored by CognifiSense.
- Recruiting
- Registry status
- NA
- Development phase
- 200
- Enrollment target
- 1
- Study location
NCT07033195: Recruiting NA study of Chronic Pain and Chronic Back Pain, sponsored by CognifiSense.
NCT07033195 is a NA study of Chronic Pain and Chronic Back Pain that is actively recruiting participants, run by CognifiSense. The registered enrollment target is 200 participants, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07033195, a NA study of Chronic Pain and Chronic Back Pain, is actively recruiting participants, sponsored by CognifiSense.
- RECRUITING
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
Participants with chronic back pain will complete an online Qualtrics eligibility survey. After signing a consent form, eligible participants enter a two-week baseline period ("Baseline Period"), during which they complete two assessments of the Primary and Secondary Outcome Measures and Potential Mediators. After the baseline period, participants are randomized into a Virtual Reality group: VR Distraction-based Therapy or VR Skills-based Therapy, with a 1:1 allocation ratio of participants to each treatment. Both groups receive education on pain neuroscience and complete training on the use of the VR hardware and software. Next, both groups complete an intervention for 8 weeks ("Treatment Period"), after which they return the VR equipment. Several surveys are administered online during the Treatment Period. After the Treatment Period, both groups complete three post-treatment surveys at weeks 8, 20, and 32.
Primary Outcome
Brief Pain Inventory-short form (BPI-SF). Measured on a Scale of 0 to 10, 0 = no pain, 10 = worst pain imaginable.
Conditions Studied
Interventions
- DEVICE Skills-based Virtual Reality Therapy
- DEVICE Distraction-based Virtual Reality Therapy
Study Locations (1)
Colorado
- University of Colorado Boulder - Boulder
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2025-06-01 |
| Est. Completion | 2026-05-31 |
| Phase | NA |
What NCT07033195 shows while recruiting
NCT07033195 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (74% lower).
The record links to 3 conditions, with Chronic Pain appearing as the primary indexed condition, and to 2 interventions - of which Skills-based Virtual Reality Therapy is the first listed.
NCT07033195 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT07033195 about?
NCT07033195 is a clinical study titled "Virtual Reality Treatment for Adults With Chronic Back Pain (VRNT)". Participants with chronic back pain will complete an online Qualtrics eligibility survey. After signing a consent form, eligible participants enter a two-week baseline period ("Baseline Period"), during which they complete two assessments of the Primary and Secondary Outcome Measures and Potential M...
What is the current status of trial NCT07033195?
This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2025-06-01. Estimated completion is 2026-05-31.
What conditions does trial NCT07033195 study?
This clinical trial studies the following conditions: Chronic Pain, Chronic Back Pain, Chronic Lower Back Pain (CLBP).
What interventions are being tested in trial NCT07033195?
The interventions under investigation include: Skills-based Virtual Reality Therapy (DEVICE), Distraction-based Virtual Reality Therapy (DEVICE).
Who is sponsoring clinical trial NCT07033195?
This trial is sponsored by CognifiSense, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07033195 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07033195's enrollment target sits among peer trials
200 83rd of 301 higher than 215 of 301 other Chronic Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Chronic Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluating the Acceptability, Feasibility and Usability of Various Conversational Data Collection Software
RECRUITING · NA
-
Local Cerebral Oxygenation in Chronic Pain Patients Utilizing Spinal Cord Stimulation
RECRUITING · NA
-
Group Medical Visits and Chiropractic Care for Older Adults With Chronic Spine Pain
RECRUITING · NA
-
Emotional Awareness and Expression Therapy for People With Persistent Pain Following Orthopedic Trauma
RECRUITING · NA
-
Group-based Integrative Pain Management in Primary Care Safety Net Clinics
RECRUITING · NA
-
Opioid and Pain Treatment in Indigenous Communities (OPTIC) Trial
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI